Search research articles
Contact Us
Filters
Showing results (201-210 of 272) with videos related to
Page
of 28
Sort By:
Clinical Colorectal Cancer
|
July 8, 2020
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial
Maria Carmela Piccirillo, Antonio Avallone, Chiara Carlomagno, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 18, 2019
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018
Maria Lucia Reale, Emmanuele De Luca, Pasquale Lombardi, et al.
BMC Cancer
|
January 10, 2006
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
Sandro Pignata, Sabino De Placido, Rosalbino Biamonte, et al.
HIV/AIDS (Auckland, N.Z.)
|
July 21, 2025
Cancer Awareness Among People Living with HIV (PLWH): Insights from an Italian Survey of Oncologists and Infectious Disease Specialists
Davide Dalu, Rosaria Iardino, Emanuela Vaccher, et al.
Critical Reviews in Oncology/Hematology
|
January 26, 2020
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018
Pasquale Lombardi, Laura Marandino, Emmanuele De Luca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2004
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study
Sabino De Placido, Giovanni Scambia, Giovanni Di Vagno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
Clinical Genitourinary Cancer
|
August 17, 2019
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018
Laura Marandino, Emmanuele De Luca, Clizia Zichi, et al.
International Journal of Cancer
|
October 17, 2024
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study
Eliana Bignotti, Vittorio Simeon, Laura Ardighieri, et al.
Journal of the National Cancer Institute
|
March 6, 2003
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial
Cesare Gridelli, Francesco Perrone, Ciro Gallo, et al.
Page
of 28
Search research articles
Search
Showing results (201-210 of 272) with videos related to
Sort By:
Page
of 28
Clinical Colorectal Cancer
|
July 8, 2020
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial
Maria Carmela Piccirillo, Antonio Avallone, Chiara Carlomagno, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 18, 2019
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018
Maria Lucia Reale, Emmanuele De Luca, Pasquale Lombardi, et al.
BMC Cancer
|
January 10, 2006
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
Sandro Pignata, Sabino De Placido, Rosalbino Biamonte, et al.
HIV/AIDS (Auckland, N.Z.)
|
July 21, 2025
Cancer Awareness Among People Living with HIV (PLWH): Insights from an Italian Survey of Oncologists and Infectious Disease Specialists
Davide Dalu, Rosaria Iardino, Emanuela Vaccher, et al.
Critical Reviews in Oncology/Hematology
|
January 26, 2020
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018
Pasquale Lombardi, Laura Marandino, Emmanuele De Luca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2004
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study
Sabino De Placido, Giovanni Scambia, Giovanni Di Vagno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
Clinical Genitourinary Cancer
|
August 17, 2019
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018
Laura Marandino, Emmanuele De Luca, Clizia Zichi, et al.
International Journal of Cancer
|
October 17, 2024
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study
Eliana Bignotti, Vittorio Simeon, Laura Ardighieri, et al.
Journal of the National Cancer Institute
|
March 6, 2003
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial
Cesare Gridelli, Francesco Perrone, Ciro Gallo, et al.
Page
of 28